Guidance
Update information
May 2019: This guideline is an update of NICE guideline CG166 (published June 2013) and replaces it.
We have reviewed the evidence on inducing remission for people with mild-to-moderate ulcerative colitis. These recommendations are marked [2019].
Recommendations marked [2008] or [2013] last had an evidence review in 2008 or 2013. In some cases minor changes have been made to the wording to bring the language and style up to date, without changing the meaning.
Minor changes since publication
February 2025: We added links to relevant technology appraisal guidance in the sections on treating moderately to severely active ulcerative colitis and treating acute severe ulcerative colitis, and added new recommendations marked [2025] clarifying how to use medicines recommended in NICE technology appraisal guidance. We moved a recommendation on monitoring treatment into the section on monitoring, and added new definitions to terms used in this guideline.
July 2019: The recommendations for research from the 2013 guideline were added.
ISBN: 978-1-4731-3392-1